Chitogenx Stock Performance

CHNXF Stock  USD 0.01  0  39.24%   
ChitogenX holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -8.64, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning ChitogenX are expected to decrease by larger amounts. On the other hand, during market turmoil, ChitogenX is expected to outperform it. Use ChitogenX coefficient of variation, total risk alpha, as well as the relationship between the Total Risk Alpha and rate of daily change , to analyze future returns on ChitogenX.

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in ChitogenX are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, ChitogenX reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow2.4 M
Total Cashflows From Investing Activities-33 K
  

ChitogenX Relative Risk vs. Return Landscape

If you would invest  0.52  in ChitogenX on November 3, 2024 and sell it today you would earn a total of  0.58  from holding ChitogenX or generate 111.54% return on investment over 90 days. ChitogenX is currently producing 2.6337% returns and takes up 20.4696% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than ChitogenX, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon ChitogenX is expected to generate 24.01 times more return on investment than the market. However, the company is 24.01 times more volatile than its market benchmark. It trades about 0.13 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.13 per unit of risk.

ChitogenX Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for ChitogenX's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as ChitogenX, and traders can use it to determine the average amount a ChitogenX's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1287

Best PortfolioBest Equity
Good ReturnsCHNXF
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 20.47
  actual daily
96
96% of assets are less volatile

Expected Return

 2.63
  actual daily
52
52% of assets have lower returns

Risk-Adjusted Return

 0.13
  actual daily
10
90% of assets perform better
Based on monthly moving average ChitogenX is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ChitogenX by adding it to a well-diversified portfolio.

ChitogenX Fundamentals Growth

ChitogenX OTC Stock prices reflect investors' perceptions of the future prospects and financial health of ChitogenX, and ChitogenX fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ChitogenX OTC Stock performance.

About ChitogenX Performance

By analyzing ChitogenX's fundamental ratios, stakeholders can gain valuable insights into ChitogenX's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ChitogenX has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ChitogenX has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada. Chitogenx is traded on OTC Exchange in the United States.

Things to note about ChitogenX performance evaluation

Checking the ongoing alerts about ChitogenX for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for ChitogenX help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
ChitogenX is way too risky over 90 days horizon
ChitogenX has some characteristics of a very speculative penny stock
ChitogenX appears to be risky and price may revert if volatility continues
ChitogenX has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (4.92 M) with profit before overhead, payroll, taxes, and interest of 0.
ChitogenX has accumulated about 2.19 M in cash with (3.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 17.0% of the company shares are held by company insiders
Evaluating ChitogenX's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate ChitogenX's otc stock performance include:
  • Analyzing ChitogenX's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ChitogenX's stock is overvalued or undervalued compared to its peers.
  • Examining ChitogenX's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating ChitogenX's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ChitogenX's management team can help you assess the OTC Stock's leadership.
  • Pay attention to analyst opinions and ratings of ChitogenX's otc stock. These opinions can provide insight into ChitogenX's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating ChitogenX's otc stock performance is not an exact science, and many factors can impact ChitogenX's otc stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for ChitogenX OTC Stock analysis

When running ChitogenX's price analysis, check to measure ChitogenX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ChitogenX is operating at the current time. Most of ChitogenX's value examination focuses on studying past and present price action to predict the probability of ChitogenX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ChitogenX's price. Additionally, you may evaluate how the addition of ChitogenX to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes